2021 Meeting

ADHD in the Era of COVID: Maintaining Focus”

The 2021 APSARD Annual Meeting was held virtually January 15-17, 2021.

For more information on the meeting click here for the official conference website.

Were you unable to attend the conference? It’s not too late! 

The APSARD Annual Meeting is an important venue for the presentation of critical information on ADHD and Related Disorders including appropriate diagnosis and assessment, current, as well as emerging, treatment paradigms and updates in science and technology advances.  It is known as a meeting which brings together multidisciplinary specialists in a collaborative atmosphere, to discuss practical, applied approaches to the management of ADHD in the real-world setting.

The 2021 Annual Meeting, held on January 15-17, 2021, focused on the scientific basis of ADHD and its treatment, including tactics and approaches that support improved care and treatment of the patient with ADHD for the complex patient, college age patient, as well as ADHD in diverse populations. The meeting provided clinicians with specific, practical information for appropriate diagnosis, assessment and treatment of ADHD in diverse setting and populations. Most importantly, the scientific basis that underlies the diagnostic and treatment approaches advocated was highlighted.  If you were not able to attend, you can still participate through April 1, 2021!

Conference Attendees: The majority of sessions have been recorded for viewing at your convenience. These recordings are available to you for 60 days after the conference. Log-In the conference platform HERE to access.

CONFERENCE LEARNING OBJECTIVES

  • The COVID-19 crisis has introduced major stressors for people with ADHD and its related disorders across many settings: home, school and the workplace. We seek submissions that will address the impact of COVID-19 on individuals and families with ADHD and which will present innovative methods of treatment that are useful during this pandemic. Submissions addressing how the pandemic will ultimately impact the care of people with ADHD are encouraged.

 

  • There are important ongoing dialogues in our country and worldwide regarding issues related to racism, racial disparities and related access to care. COVID-19 has disproportionately affected disadvantaged communities and people of color due to disparities in many social determinates of health. But these issues extend well beyond COVID-19, and pose important issues related to health care in general, and care of individuals and families with ADHD, in particular. APSARD seeks proposals that will address critical issues in this area.

Press and Press Releases
No members of the press are allowed to attend the APSARD Annual Meeting unless they are approved or invited.
Press Requests will be funneled in the following way:
− Press request emailed to info@apsard.org
− Executive Office requests press’ credentials
− Executive Office sends request and credentials for approval to the APSARD President and designated member of the APSARD Social Media and Website Committee for approval
− Pending approval, Executive Office provides registration link with promo-code for waived registration.
Any press release issued by a presenter, the presenter’s employer, or any other outside person or entity about a presentation scheduled for the APSARD Annual Meeting must be embargoed until the time and date of the presentation and should be clear that it is not sanctioned by APSARD. See Appendix II for the full press code of conduct.

Embargo Policy
Press releases and sessions are embargoed until the meeting date and time of the presentation. APSARD strictly enforces its embargo policy, which prohibits the publication of research ahead of the embargo date and time. Proper sourcing of research partners and attribution to APSARD and the APSARD Annual Meeting are required. Press Releases or summaries of content from the meeting must be approved by the presenting author before release.